Anterior chamber migration of dexametasone intravitreal implant (Ozurdex

Volume: 250, Issue: 11, Pages: 1703 - 1704
Published: Nov 1, 2012
Abstract
Dear Editor, Ozurdex® (Allergan Inc., Irvine, CA, USA) is an intravitreal implant containing the dexamethasone. It uses NOVADUR® drug delivery technology, in which a biodegradable material is combined with the active drug dexamethasone to form a small rod-shaped implant of 0.46 mm in diameter and 6 mm in length. Inside the eye, the implant is progressively dissolved in the vitreous gel, as it slowly releases dexamethasone (0.7 mg). This...
Paper Details
Title
Anterior chamber migration of dexametasone intravitreal implant (Ozurdex
Published Date
Nov 1, 2012
Volume
250
Issue
11
Pages
1703 - 1704
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.